Anti-Cancer Drug Reverses Alzheimer's disease
(Ivanhoe Newswire) -- Researchers at the University of Pittsburgh Graduate School of Public Health have found that an anti-cancer drug is effective in reversing the memory deficits in an Alzheimer's disease mouse model.
Researchers were able to verify that bexarotene, a drug most commonly used to fight lymphoma, does significantly improve cognitive deficits in mice expressing gene mutations linked to human Alzheimer's disease.
"We believe these findings make a solid case for continued exploration of bexarotene as a therapeutic treatment for Alzheimer's disease," senior author Rada Koldamova, MD, PhD, associate professor in Pitt Public Health's Department of Environmental and Occupational Health, was quoted as saying.
For more information go to:
SOURCE: Science, May 2013
Click Here for a free weekly email with Ivanhoe's latest Medical Breakthroughs.